Selected article for: "acquisition risk and acute respiratory syndrome coronavirus"
Author: Kernéis, Solen; Planas, Delphine; Imbeaud, Sandrine; Staropoli, Isabelle; Puech, Julien; Robillard, Nicolas; Rodary, Julien; Bruel, Timothée; Vieillard, Thomas; Schwartz, Olivier; Belec, Laurent; Péré, Hélène; Veyer, David
Title: Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual
  • Cord-id: jlnt1pdd
  • Document date: 2021_7_20
    • ID: jlnt1pdd
    Snippet: Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.
    Document: Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acquisition after vaccination with BNT162b2 have been described, but the risk of secondary transmission from fully vaccinated individuals remains ill defined. Herein we report a confirmed transmission of SARS-CoV-2 alpha variant (B.1.1.7) from a symptomatic immunocompetent woman 4 weeks after her second dose of BNT162b2, despite antispike seroconversion.

    Search related documents:
    Co phrase search for related documents
    • abbott sars and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abbott sars and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abbott sars and live virus neutralization: 1
    • abbott sars immunoglobulin and acute respiratory syndrome: 1, 2, 3, 4
    • abbott sars immunoglobulin and acute respiratory syndrome coronavirus: 1, 2, 3, 4
    • abbott sars immunoglobulin and live virus neutralization: 1
    • absolute risk and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • absolute risk and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • absolute risk and local area: 1
    • acquisition source and acute respiratory syndrome: 1
    • acquisition source and acute respiratory syndrome coronavirus: 1
    • acute respiratory syndrome and live virus neutralization: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory syndrome and local area: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome coronavirus and live virus neutralization: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome coronavirus and local area: 1, 2, 3